Neuractas is interested in marketing quinacrine (also known as mepacrine) as a drug product. You list quinacrine/mepacrine as a \"special raw material\" in your catalogue. Would you be able to produce API-grade quinacrine? Any clarification you could provide to help me understand how \"special raw material\" is different from your other offerings would be helpful too. Thanks.